These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27815067)

  • 1. ART regimes and fat: the healing hand wielding the sword.
    Domingo P; Espinet J; Vidal F
    Lancet HIV; 2017 Jan; 4(1):e2-e3. PubMed ID: 27815067
    [No Abstract]   [Full Text] [Related]  

  • 2. What does the term "HIV-associated lipodystrophy" mean?
    Marcason W
    J Am Diet Assoc; 2009 Feb; 109(2):364. PubMed ID: 19167963
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV and increased risk of cardiovascular diseases.
    Das S
    Sex Health; 2005; 2(4):219-21. PubMed ID: 16402668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART?
    Vella S; Palmisano L
    J HIV Ther; 2003 May; 8(2):27-8. PubMed ID: 15587479
    [No Abstract]   [Full Text] [Related]  

  • 5. Sweetening the toxic cocktail. Managing the side effects of HIV medications.
    Doerfler RE
    Adv Nurse Pract; 2002 May; 10(5):52-4, 57-8, 103. PubMed ID: 12420531
    [No Abstract]   [Full Text] [Related]  

  • 6. Case files from the Bellevue Hospital Center at New York University--lipoatrophy following long-term antiretroviral therapy.
    Daskalakis D; Aberg JA
    MedGenMed; 2005 Oct; 7(4):9. PubMed ID: 16614631
    [No Abstract]   [Full Text] [Related]  

  • 7. Stavudine in antiretroviral therapy: is this the end?
    Brinkman K
    AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
    [No Abstract]   [Full Text] [Related]  

  • 8. Current perspectives on the management and prevention of antiretroviral-associated lipoatrophy.
    Phillips DR; Hay P
    J Antimicrob Chemother; 2008 Nov; 62(5):866-71. PubMed ID: 18703527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Criteria for AIDS-prices 2003. Why does HAART therapy in HIV patients cause fat catabolism?].
    Urologe A; 2003 Sep; 42(9):1254. PubMed ID: 14619845
    [No Abstract]   [Full Text] [Related]  

  • 10. [HIV lipodystrophy syndrome: a new challenge to the endocrinologist].
    Valente O; Valente AM
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):3-4. PubMed ID: 17435848
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic complications of HIV therapy in children.
    McComsey GA; Leonard E
    AIDS; 2004 Sep; 18(13):1753-68. PubMed ID: 15316336
    [No Abstract]   [Full Text] [Related]  

  • 12. The HIV-1/HAART associated metabolic syndrome - novel adipokines, molecular associations and therapeutic implications.
    Tsiodras S; Perelas A; Wanke C; Mantzoros CS
    J Infect; 2010 Jul; 61(2):101-13. PubMed ID: 20547180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Deviating from classical triple therapy. Nuke sparing concepts as interest focus].
    MMW Fortschr Med; 2011 May; 153(18):38. PubMed ID: 21604594
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of lipoatrophy after a four-year long interruption of antiretroviral therapy for HIV1 infection: case report.
    Parruti G; Toro GM
    BMC Infect Dis; 2005 Oct; 5():80. PubMed ID: 16202141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between lipodystrophy and leptin in human immunodeficiency virus-1-infected children receiving lopinavir/ritonavir-based therapy.
    Resino S; Palladino C; Lorente R; Micheloud D; Bellón JM; Larru B; Gutiérrez MD; de José MI; Polo R; Muñoz-Fernández MA;
    Pediatr Infect Dis J; 2010 Aug; 29(8):774-7. PubMed ID: 20375850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral lipomastia in men: a side effect of highly active antiretroviral therapy.
    Deonarain J; Ramdial PK; Singh B
    Int J Surg Pathol; 2008 Apr; 16(2):171-5. PubMed ID: 18417674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approaches to combating lipoatrophy: do they work?
    Martin A; Mallon PW
    J Antimicrob Chemother; 2005 May; 55(5):612-5. PubMed ID: 15761072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 19. Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV type 1-infected patients receiving highly active antiretroviral therapy.
    Asensi V; Martín-Roces E; Carton JA; Collazos J; Maradona JA; Alonso A; Medina M; Aburto JM; Martínez E; Rojo C; Bustillo E; Fernández C; Arribas JM
    Clin Infect Dis; 2004 Jul; 39(2):240-7. PubMed ID: 15307034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
    Falutz J
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.